Veterans Affairs banner with U.S. Flag

VA National Clinical Public Health Programs — HIV/AIDS

www.hiv.va.gov

Send to printer
< Close window

Disclaimer: This information is not meant to substitute for professional advice; please consult your medical provider or pharmacist.

Drug Dosing Toolkit

Intelence (etravirine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
(NNRTI, nonnucleoside, "nonnuke")

Approved adult dosing

two 100 mg tablets, twice a day after meals

  • Morning

    Intelence 100mgIntelence 100mg

    Intelence

  • Evening

    Intelence 100mgIntelence 100mg

    Intelence

Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.

My doctor's instructions

Notes on taking this medication

  • Take after a meal (do not take without food)
  • Intelence can interact with other drugs; consult your medical provider

Side effects

  • Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
  • Nausea
  • Intelence has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug
^ Back to the topProviders' HomePatients' Home